Buy and Hold RANBAXY at Rs590, for 30 days target Rs650,700

Buy and Hold RANBAXY at Rs590, for 30 days target Rs650,700

Ranbaxy settles worldwide patent litigations with Pfizer. Under the agreement, Ranbaxy will be allowed to sell generic versions of the drug in the US from November 30, 2011. (BL)

.